DRUG

Bright Minds Biosciences Inc.

1.88 USD
+0.06 (+3.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bright Minds Biosciences Inc. stock is down -12.56% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 February’s closed higher than January.

About Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.